Internal Medicine, Hematology & Oncology · Santa Monica, CA
NPI
1922341205
Since 2013
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2020 Santa Monica Blvd Ste 600
Santa Monica, CA, 90404
Phone (310) 829-5471
Groups this clinician bills Medicare through
Medicare paid, 2024
$759K
30,507 services
Medicare patients, 2024
244
Average age 72
Drug cost, 2024
$3.6M
470 prescriptions
Company payments, 2025
$147
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven C Tsai was code J1100 (injection, dexamethasone sodium phosphate, 1 mg), 510 times for 11 patients. In total Steven C Tsai billed 30,507 services in 94 codes, and Medicare paid $759K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 510 | 11 | $0.09 | $45.61 |
| 99233 Hospital E&M - Subsequent | Facility | 340 | 76 | $96.91 | $33K |
| 96375 Injection Administration | Office | 152 | 18 | $13.82 | $2,100 |
| 85025 Blood Count | Office | 129 | 52 | $7.55 | $974 |
| 99215 Office E&M - Established | Facility | 102 | 23 | $115.73 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 79 | 20 | $13.56 | $1,071 |
| 99215 Office E&M - Established | Office | 72 | 27 | $151.61 | $11K |
| 96413 Chemotherapy Administration | Office | 65 | 16 | $117.21 | $7,618 |
| 96372 Injection Administration | Office | 65 | 17 | $12.21 | $793 |
| 96365 Intravenous Infusion, Hydration | Office | 47 | 26 | $56.03 | $2,633 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 43 | 12 | $0.49 | $21.22 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 42 | 11 | $0.64 | $26.98 |
| 99239 Hospital Discharge Management | Facility | 36 | 30 | $95.68 | $3,444 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 34 | 16 | $13.33 | $453 |
| 99214 Office E&M - Established | Office | 32 | 24 | $94.83 | $3,034 |
By year: 2022 $213K for 10,958 services; 2023 $353K for 15,802 services; 2024 $759K for 30,507 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 129 | 52 | $7.55 | $974 |
| 36415 Venipuncture Blood Collection | 29 | 20 | $8.65 | $251 |
Medicare prescription drug claims, 2024
In 2024, the drug Steven C Tsai prescribed most often to Medicare patients was Acyclovir, with 51 prescriptions and refills. In total Steven C Tsai wrote 470 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 51 | 151 | 22 | $1,642 |
| Xarelto Rivaroxaban | 32 | 50 | Under 11 | $26K |
| Venclexta Venetoclax | 29 | 29 | Under 11 | $245K |
| Xospata Gilteritinib Fumarate | 24 | 24 | Under 11 | $446K |
| Eliquis Apixaban | 21 | 55 | Under 11 | $32K |
| Revlimid Lenalidomide | 19 | 19 | Under 11 | $237K |
| Cresemba Isavuconazonium Sulfate | 17 | 25 | Under 11 | $150K |
| Ojjaara Momelotinib Dihydrochloride | 17 | 17 | Under 11 | $827K |
| Hydroxyurea Generic | 14 | 36 | Under 11 | $420 |
| Iclusig Ponatinib Hcl | 13 | 13 | Under 11 | $380K |
| Levofloxacin Generic | 12 | 20 | Under 11 | $162 |
| Posaconazole Generic | 11 | 19 | Under 11 | $24K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 11 | 11 | Under 11 | $432 |
Brand drugs: - claims; generic drugs: 234 claims; opioid claims: 25.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven C Tsai $147 ($147 in general payments such as food, travel and fees) from 5 companies. The largest payer was Seagen Inc. with $92.99.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.